Health

New York Times  - An experimental vaccine developed by Merck and Moderna could become the first vaccine of its kind used to treat cancer. Scientists hope it won’t be the last. On Thursday, the drug makers announced that patients with melanoma who received a vaccine tailored to help their immune systems attack their tumors were 42 percent less likely to experience a recurrence of the cancer within two years than those who did not receive the vaccine. The companies have yet to show the treatment can prolong melanoma patients’ overall survival.

Maine Morning Star - The percentage of working-age adults without health insurance has increased in the past two years, largely because many people can no longer afford Obamacare coverage after Congress allowed federal subsidies to expire at the end of last year.

The uninsured rate for adults ages 19-64 rose to 11.2% this year, up from 8.9% in 2024, according to a new analysis by the Commonwealth Fund, a health policy and philanthropic nonprofit.

Nearly half of the 7,362 working-age adults who participated in the group’s biennial health insurance survey said they were uninsured, underinsured, or experienced a gap in coverage this year. Half said they delayed or avoided getting medical care because of the cost, compared with 46% in 2022. 

The Guardian -  US vaccine recommendations are in limbo, access to vaccines is suffering, and some of the uncertainty may continue for years following major blows to vaccination by the Trump administration, experts say.

Robert F Kennedy Jr, the secretary of the US Department of Health and Human Services (HHS), has made sweeping changes to vaccination policy, cutting childhood immunization recommendations by a third and replacing experts on the Advisory Committee on Immunization Practices (ACIP) with his own handpicked allies.

A judge’s order halted these changes because they were not done correctly, but Kennedy has not nominated any new ACIP members – which means there are no new vaccination recommendations coming from the committee, even as new vaccines are approved.